General Information of the Compound
Compound ID
CP0136263
Compound Name
(3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethylspiro[2,3,4,6,6a,6b,7,8,11,11a-decahydro-1H-benzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-ol
    Show/Hide
Synonyms
(3beta,22S,23R)-17,23-epoxyveratraman-3-ol
11-Deoxojervine
11-Deoxyjervine
4449-51-8
AC1L9DRQ
CHEBI:4021
CHEMBL254129
CY8
CYCLOPAMINE
DSSTox_CID_23709
DSSTox_RID_80067
HSDB 3505
Jervine, 11-deoxo-
SCHEMBL29153
Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)- (9CI)
UNII-ZH658AJ192
Veratraman-3-ol, 17,23-epoxy-, (3beta,23beta)-
ZH658AJ192
[3H]-Cyclopamine
    Show/Hide
Structure
Formula
C27H41NO2
Molecular Weight
411.63
Canonical SMILES
C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC2=C1C
    Show/Hide
InChI
InChI=1S/C27H41NO2/c1-15-11-24-25(28-14-15)17(3)27(30-24)10-8-20-21-6-5-18-12-19(29)7-9-26(18,4)23(21)13-22(20)16(27)2/h5,15,17,19-21,23-25,28-29H,6-14H2,1-4H3/t15-,17+,19-,20-,21-,23-,24+,25-,26-,27-/m0/s1
    Show/Hide
InChIKey
QASFUMOKHFSJGL-LAFRSMQTSA-N
CAS
4449-51-8
Physicochemical Property
logP
5.0019
Rotatable Bonds
0
Heavy Atom Count
30
Polar Areas
41.49
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 442972
SID: 14928900
ChEMBL ID
CHEMBL254129
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04361, Protein smoothened
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 64 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 280 nM
   TI
   LI
   LO
   TS
CL000426 Shh Light II Mus musculus (Mouse)  1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
Protein ID: PT02397, Protein smoothened
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CL001057 Ptch-deficient MEF Mus musculus (Mouse)  2
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
2
IC50 = 1900 nM
   TI
   LI
   LO
   TS
Protein ID: PT02715, Sonic hedgehog protein
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000426 Shh Light II Mus musculus (Mouse)  1
1
IC50 = 1312 nM
   TI
   LI
   LO
   TS
Protein ID: PT03751, Zinc finger protein GLI1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000426 Shh Light II Mus musculus (Mouse)  1
1
IC50 = 5000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( CYCLOPAMINE )
Drug Name CYCLOPAMINE
Target(s)
Smoothened homolog (SMO)
Inhibitor